ZIM Laboratories Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

111.20 -0.20 (-0.18%)Updated : 11 Jun 2026

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	364.37	354.70	341.85	364.01
Other Net	11.38	-1.53	-0.28	-0.28
Diluted Weighted Average Shares	4.91	4.87	4.87	4.87
Depreciation/ Amortization	19.98	20.11	15.95	17.47
Operating Income	10.03	24.33	25.57	34.52
Net Income	5.84	12.17	17.25	24.43
Income Availableto Com Excl Extra Ord	5.84	12.17	17.25	24.43
Other Operating Expenses Total	115.11	3.86	4.44	4.35
Net Income Before Taxes	8.21	18.01	23.64	35.36
Minority Interest	0.00	0.00	0.00	-
Net Income After Taxes	5.84	12.17	17.25	24.43
Income Availableto Com Incl Extra Ord	5.84	12.17	17.25	24.43
Costof Revenue Total	165.37	185.94	185.68	210.90
Gross Profit	209.03	193.09	181.74	187.63
Interest Inc( Exp) Net- Non- Op Total	-13.20	-4.79	-1.63	1.12
Diluted Net Income	5.84	12.17	17.25	24.43
Provisionfor Income Taxes	2.37	5.84	6.40	10.92
period Type	-	-	-	-
Net Income Before Extra Items	5.84	12.17	17.25	24.43
Total Revenue	374.40	379.03	367.42	398.53
period Length	12.00	12.00	12.00	12.00
Revenue	374.40	379.03	367.42	398.53
Selling/ General/ Admin Expenses Total	63.90	144.65	135.78	130.64
Diluted Normalized EPS	1.19	2.52	3.54	5.11
Diluted EPS Excluding Extra Ord Items	1.19	2.50	3.54	5.01
Gain( Loss)on Saleof Assets	-	0.00	-0.02	-
Unusual Expense( Income)	-	0.14	0.00	0.66